abstract |
Amorphous and crystalline solid forms of (E) -1- (4 - ((1R, 2S, 3R) -1,2,3,4-tetrahydroxybutyl) -1H-imidazol-2-yl) ethanone oxime are presented. These particular solid forms can be used as sphingosine-1-phosphate modulators for the treatment of autoimmune and inflammatory diseases. |